R&D | December 08, 2025
B Braun unveils ready-to-use antibiotic system
DUPLEX’s two-compartment, PVC- and DEHP-free design keeps medication and diluent separate until activation
DUPLEX’s two-compartment, PVC- and DEHP-free design keeps medication and diluent separate until activation
Senores Pharmaceuticals is poised to accelerate its presence in the Asia-Pacific region
Grant of Permission to manufacture and market FDC of Naproxen Delayed Release and Esomeprazole capsule (375mg/500mg + 20mg/20mg)
EBITDA stood at Rs. 100.1 crore with a margin of 16.1 per cent
The company reported revenue from operations at Rs. 6,573.7 crore, up 6 per cent YoY
The performance was below anticipated levels, primarily due to external factors such as seasonal disruption that affected overall results
The portfolio consists of liquids and immediate release solid orals which are in the therapeutic segment to treat infections associated with UTIs
Innovative chronic pain treatment receives IP protection in India's $55 billion pharmaceutical market
The Union Budget 2025-26 strengthens India's healthcare sector with an allocation of Rs. 99,858.56 crore, marking a 9.78% rise from Rs. 90,958.63 crore in 2024-25
Subscribe To Our Newsletter & Stay Updated
_256_384.JPG)
